We’ve carved out subsets from Wall Street’s oversimplified classification of drug stocks.
Apr
05
2003
Cutting The Drug Business Five Ways
Login
For full access, please enter your credentials.
Not a Subscriber?
If you are interested in subscribing to The Leuthold Group, contact us online or give us a call at 612-332-1567.
Contact UsAbout The Authors
current issue
featured articles
recent tags
Japan
(47)
Factor Performance
(17)
Wealth Effect
(9)
Bank Lending
(1)
Dollar
(55)
Inflation
(584)
Resession
(1)
Time Cycles
(6)
Breakeven Rate
(1)
Oil
(48)
Value
(130)
Treasuries
(79)
Long T-Bonds
(24)
Active vs. Passive
(17)
Yield Curve
(85)
Economy
(282)
Federal Spending
(2)
Stock Market Performance
(1)
Fed Policy
(173)
Federal Debt/Deficit
(194)